Prolactinoma Screening: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
m (Bot: Removing from Primary care) |
||
| Line 12: | Line 12: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
| |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Neuroendocrinology]] | [[Category:Neuroendocrinology]] | ||
| Line 17: | Line 19: | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Up-To-Date | [[Category:Up-To-Date]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Neurosurgery]] | [[Category:Neurosurgery]] | ||
Latest revision as of 23:50, 29 July 2020
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma Screening On the Web |
|
American Roentgen Ray Society Images of Prolactinoma Screening |
|
Risk calculators and risk factors for Prolactinoma Screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for prolactinoma.
Screening
There is insufficient evidence to recommend routine screening for prolactinoma.
References